menu
    • menu

    Company profile for Madrigal Pharmaceuticals

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Madrigal Pharmaceuticals is a clinical-stage biopharmaceutical company pursuing novel therapeutics that target a specific thyroid hormone pathway in the liver, which is a key regulatory mechanism common to a spectrum of cardio-metabolic and fatty liver diseases with high unmet medical need.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Madrigal PharmaceuticalsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    200 Barr Harbor Drive Suite 200 West Conshohocken, PA 19428
    Telephone
    Telephone
    (267) 327-4445
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.madrigalpharma.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Madrigal Pharma Awards Inducement Grants Per Nasdaq LR 5635(C)(4)
    Madrigal Pharma Awards Inducement Grants Per Nasdaq LR 5635(C)(4)

    20 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/20/3192374/0/en/Madrigal-Pharmaceuticals-Announces-Grants-of-Inducement-Awards-under-Nasdaq-Listing-Rule-5635-c-4.html

    GLOBENEWSWIRE
    20 Nov 2025
    Share Share
    Madrigal Pharma To Attend 3 Investor Conferences
    Madrigal Pharma To Attend 3 Investor Conferences

    17 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/17/3189052/0/en/Madrigal-Pharmaceuticals-Announces-Participation-at-Three-Upcoming-Investor-Conferences.html

    GLOBENEWSWIRE
    17 Nov 2025
    Share Share
    Madrigal Shows Rezdiffra Boosts Imaging And Biomarkers
    Madrigal Shows Rezdiffra Boosts Imaging And Biomarkers

    10 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/10/3184462/0/en/Madrigal-Presents-New-Data-Demonstrating-Rezdiffra-resmetirom-Significantly-Improved-Multiple-Noninvasive-Imaging-Tests-and-Biomarkers-in-Patients-with-Compensated-MASH-Cirrhosis.html

    GLOBENEWSWIRE
    10 Nov 2025
    Share Share
    Madrigal Pharma Grants Inducement Awards Under Nasdaq LR
    Madrigal Pharma Grants Inducement Awards Under Nasdaq LR

    06 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/06/3183082/0/en/Madrigal-Pharmaceuticals-Announces-Grants-of-Inducement-Awards-under-Nasdaq-Listing-Rule-5635-c-4.html

    GLOBENEWSWIRE
    06 Nov 2025
    Share Share
    Madrigal's MASH Drug Rezdiffra Posts 35% Sales Increase In Q3
    Madrigal's MASH Drug Rezdiffra Posts 35% Sales Increase In Q3

    05 Nov 2025

    // FIERCE PHARMA

    https://www.fiercepharma.com/pharma/madrigal-reports-sales-boost-rezdiffra-while-welcoming-novo-mash-market

    FIERCE PHARMA
    05 Nov 2025
    Share Share
    Madrigal To Unveil Latest MASH Program Data At AASLD Meeting
    Madrigal To Unveil Latest MASH Program Data At AASLD Meeting

    28 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/28/3175355/0/en/Madrigal-to-Present-New-Data-from-the-Company-s-MASH-Program-at-AASLD-s-The-Liver-Meeting-2025.html

    GLOBENEWSWIRE
    28 Oct 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search